Source: Health Canada shortage reports · Updated Jul 24, 2026
Some Paroxetine products are in shortage in Canada (3 of 33 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 18, 2026.
An antidepressant (SSRI) used to treat depression and anxiety disorders.
Products affected
3 / 33
In shortage since
Feb 4, 2026
Est. full return
Dec 18, 2026
Reports on file
103
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
PMS-PAROXETINE
10MG · TABLET
TABLET · PHARMASCIENCE INC
DIN 02247750 · since Jul 10, 2026, est. end Aug 5, 2026 · Disruption of the manufacture of the drug.
Active shortage
PAXIL TAB 20MG
20MG · TABLET · GLAXOSMITHKLINE INC
DIN 01940481 · since Apr 30, 2026, est. end Dec 18, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-PAROXETINE
30MG · TABLET · TEVA CANADA LIMITED
DIN 02248558 · since Feb 4, 2026, no end estimate · Disruption of the manufacture of the drug.
DIN 02248503 · Disruption of the manufacture of the drug.
Resolved
TEVA-PAROXETINE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02248556 · ended Jun 16, 2026 · Disruption of the manufacture of the drug.
Discontinued
PAXIL TAB 30MG
30MG · TABLET · GLAXOSMITHKLINE INC
DIN 01940473
reversed
TEVA-PAROXETINE
20MG · TABLET · TEVA CANADA LIMITED
DIN 02248557
reversed
TEVA-PAROXETINE
20MG · TABLET · TEVA CANADA LIMITED
DIN 02248557
reversed
TEVA-PAROXETINE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02248556
Discontinued
PAXIL TAB 10MG
10MG · TABLET · GLAXOSMITHKLINE INC
DIN 02027887
Resolved
TEVA-PAROXETINE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02248556 · ended Mar 19, 2025 · Shortage of an inactive ingredient or component.
Discontinued
TEVA-PAROXETINE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02248556
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Paroxetine is currently affected by 3 active shortage reports filed with Health Canada by PHARMASCIENCE INC, GLAXOSMITHKLINE INC, TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Paroxetine is classified under “ANTIDEPRESSANTS” (ATC N06AB).
Recent changes
Jul 13, 2026
New report filed
Common questions
What is Paroxetine used for?
An antidepressant (SSRI) used to treat depression and anxiety disorders.
When will Paroxetine be back in stock in Canada?
The latest manufacturer estimate is Dec 18, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Paroxetine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.